Werewolf Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Werewolf Therapeutics, Inc. (HOWL) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents111.00134.34129.32157.5392.57
Cash & Short-Term Investments111.00134.34129.32157.5392.57
Accounts Receivable0.001.356.930.000.00
Inventory0.000.000.000.000.00
Other Current Assets2.072.683.963.440.34
Total Current Assets113.07138.37140.20161.0792.91
Non-Current Assets
Property, Plant & Equipment (Net)12.3214.8517.4516.333.12
Long-Term Investments1.220.000.000.000.00
Other Non-Current Assets0.3221.622.591.860.21
Total Non-Current Assets13.8636.4620.0518.180.00
Total Assets126.93174.83160.25179.2596.40
Current Liabilities
Accounts Payable3.041.341.2210.801.02
Short-Term Debt3.116.670.000.000.00
Current Portion of Long-Term Debt0.006.670.000.000.00
Accrued Liabilities10.235.2310.458.603.49
Deferred Revenue0.000.916.530.000.00
Other Current Liabilities9.030.450.572.200.09
Total Current Liabilities15.1819.3823.9911.875.28
Non-Current Liabilities
Long-Term Debt35.5332.6612.6014.590.00
Other Non-Current Liabilities2.831.340.190.000.03
Total Non-Current Liabilities38.3644.0813.9214.590.00
Total Liabilities53.5463.4637.9126.467.18
Stockholders' Equity
Common Stock0.010.000.000.000.00
Retained Earnings-414.59-344.07-306.71-252.90-51.87
Additional Paid-in Capital487.97455.44429.04405.680.00
Shares Outstanding44.8339.1131.4327.310.00
Total Stockholders' Equity73.39111.37122.34152.7989.22
Total Liabilities & Equity126.93174.83160.25179.250.00